Annexin A1 (D5V2T) XP® Rabbit mAb (PE Conjugate) #80994
- F
Supporting Data
REACTIVITY | H |
SENSITIVITY | Endogenous |
MW (kDa) | |
Source/Isotype | Rabbit IgG |
Application Key:
- F-Flow Cytometry
Species Cross-Reactivity Key:
- H-Human
Product Information
Product Description
Product Usage Information
Application | Dilution |
---|---|
Flow Cytometry (Fixed/Permeabilized) | 1:50 |
Storage
Protocol
Specificity / Sensitivity
Species Reactivity:
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human annexin A1 protein.
Background
The annexin superfamily consists of 13 calcium or calcium and phospholipid binding proteins with high biological and structural homology (1). Annexin-1 (ANXA1) is the first characterized member of the annexin family of proteins and is able to bind to cellular membranes in a calcium-dependent manner, promoting membrane fusion and endocytosis (2-4). Annexin A1 has anti-inflammatory properties and inhibits phospholipase A2 activity (5,6). Annexin A1 can accumulate on internalized vesicles after EGF-stimulated endocytosis and may be required for a late stage in inward vesiculation (7). Phosphorylation by PKC, EGFR, and Chak1 results in inhibition of annexin A1 function (8-10). Annexin A1 has also been identified as one of the 'eat-me' signals on apoptotic cells that are to be recognized and ingested by phagocytes (11). Annexin A1, as an endogenous anti-inflammatory mediator, has roles in many diverse cellular functions, such as membrane aggregation, inflammation, phagocytosis, proliferation, apoptosis, and tumorigenesis and cancer development (12-14).
- Raynal, P. and Pollard, H.B. (1994) Biochim Biophys Acta 1197, 63-93.
- Blackwell, G.J. et al. (1980) Nature 287, 147-9.
- Rothhut, B. et al. (1983) Biochem Biophys Res Commun 117, 878-84.
- Hirata, F. et al. (1981) Proc Natl Acad Sci USA 78, 3190-4.
- Kim, K.M. et al. (1994) FEBS Lett 343, 251-5.
- Kim, S.W. et al. (2001) J Biol Chem 276, 15712-9.
- White, I.J. et al. (2006) EMBO J 25, 1-12.
- Varticovski, L. et al. (1988) Biochemistry 27, 3682-90.
- Dorovkov, M.V. and Ryazanov, A.G. (2004) J Biol Chem 279, 50643-6.
- Wang, W. and Creutz, C.E. (1994) Biochemistry 33, 275-82.
- Arur, S. et al. (2003) Dev Cell 4, 587-98.
- Perretti, M. and Gavins, F.N. (2003) News Physiol Sci 18, 60-4.
- Parente, L. and Solito, E. (2004) Inflamm Res 53, 125-32.
- Lim, L.H. and Pervaiz, S. (2007) FASEB J 21, 968-75.
限制使用
除非 CST 的合法授书代表以书面形式书行明确同意,否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件,除非书 CST 的合法授书代表以书面形式书独接受, 否书均被拒书,并且无效。
专品专有“专供研究使用”的专专或专似的专专声明, 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的, 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专,且专用于研专用途。将专品用于专断、专防或治专目的, 或专专售(专独或作专专成)或其他商专目的而专专专品,均需要 CST 的专独专可。客专:(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品,或使用专品制造任何商专专品,(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专,或使用专品开专任何与 CST 的专品或服专专争的专品或服专, (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专,(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品, (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专